Back to Superinvestors
SUPERINVESTOR HOLDERS

ALLO

Allogene Therapeutics Inc
Healthcare · Biotechnology
Holders
3
Total value
$31,504,729
Total shares
15,146,504
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
PRIMECAP Management
PRIMECAP Management Co
13,123,440 $27,296,756 0.02% ADD +4,743,600 30 Jun 2026
Cliff Asness
AQR Capital Management
2,006,288 $4,173,079 0.00% REDUCE -478,492 30 Jun 2026
Murray Stahl
Horizon Kinetics LLC
16,776 $34,894 0.00% REDUCE -806 30 Jun 2026